Protocol of HOTFy: randomised clinical trial to hyperbaric oxygen therapy in fibromyalgia.

Fibromyalgia is a polysymptomatic syndrome with a prevalence between 0.2% and 13% of the population and causes work disabilities in approximately half of affected patients. The results will be disseminated via publications in peer-reviewed journals and presentations in medical meetings.

⚡ This is an original paraphrased summary — not copied from the abstract. Full paper available at the source link below.

• 1 Several treatments to fibromyalgia have been proposed with partial improvement.
• 2 This study aims to evaluate the efficacy of hyperbaric oxygen therapy and when it should be introduced to fibromyalgia.
• 3 This is a protocol for an open-label, crossover, randomised clinical trial comparing treatment with hyperbaric oxygen therapy and standardised treatment to fibromyalgia.

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

This summary is based on publicly available metadata and abstract. For the full research paper, visit the original source: